About Roselabs Bioscience Limited
Data last updated:
Roselabs Bioscience Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 06 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2010PLC059109. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹29 Cr and a paid-up capital of ₹28.9 Cr. It was formerly known as Roselabs Bioscience Private Limited. It is led by directors including Pawankumar Trilokchand Agrawal and Rahul Rajkumar Agrawal.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2020, the company reported a revenue of ₹12.39 Cr, a decline of 56% compared to the previous year. For the same year it recorded a net loss of ₹6.94 Cr (net margin -56%) and EBITDA of ₹4.85 Cr (EBITDA margin 39.2%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹462.38 Cr and satisfied charges of ₹14.62 Cr on record. Court records list 67 cases involving the company, including 4 filed by the company and 63 filed against it; 30 cases are pending. The company has 13 deals on record (7 funding rounds, 6 secondary share transfers), with disclosed funding of ₹94.34 Cr; the latest was in March 2019. Its 4 peer companies in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger; the largest is Outcare Medical Devices Private Limited with revenue of ₹12.84 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website roselabsindia.com.
Company details
CIN history
Roselabs Bioscience has one previous CIN (Corporate Identification Number): U24290GJ2010PTC059109. The current CIN is U24290GJ2010PLC059109, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24290GJ2010PLC059109 | Current |
| U24290GJ2010PTC059109 | Previous |
Contact details
Roselabs Bioscience Limited's registered office is in Ahmedabad, Gujarat. Its website is roselabsindia.com. Its telephone number is in the company report.
- Telephone
- Website
- Registered AddressC – 1206 Siddhivinayak Towers B/H Adani Cng Pump Off. Sg Highway Maka, Rba, Ahmedabad, Gujarat, India – 380051
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Roselabs Bioscience Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Roselabs Bioscience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Roselabs Bioscience Limited, buy the company report.
Financials of Roselabs Bioscience Limited
FY 2020 filings availableRoselabs Bioscience Limited reported revenue of ₹12.39 Cr (down 56% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 56% fall in the latest year. EBITDA rose 277% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹12.39 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.85 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.94 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 39.2% | ||||
| Net Profit Margin | -56% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Roselabs Bioscience Limited, buy the company report.
Board of directors of Roselabs Bioscience Limited
Roselabs Bioscience has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawankumar Trilokchand Agrawal | Director | 06 Jan 2010 | 16 Years 10 Months | Current |
| Rahul Rajkumar Agrawal | Director | 21 May 2016 | 10 Years 5 Months | Current |
| Zameer Pawankumar Agrawal Also directs: Roselabs Limited, Roselabs Polymers Limited, Pushpdant Commotrade Private Limited and 1 more | Director | 06 Jan 2010 | 16 Years 10 Months | Current |
Peer comparison
Roselabs Bioscience Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Outcare Medical Devices Private Limited | ₹12.84 Cr (FY 2024) | 141.0% | Hyderabad, Telangana, India | |||
| Peekay Mediequip Limited | ₹12.77 Cr (FY 2017) | 157.0% | Tanjore, Tamil Nadu, India | |||
| Sangam Health Care Products Ltd | ₹12.48 Cr (FY 2025) | 3.0% | Hyderabad, Telangana, India | |||
| H&H Health Care & Cosmetics Private Limited | ₹12.48 Cr (FY 2025) | 4064.0% | Indore, Madhya Pradesh, India | |||
| Roselabs Bioscience Limitedthis company | ₹12.39 Cr (FY 2020) | -₹6.94 Cr | -56% | -56.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Roselabs Bioscience Limited, buy the company report.
Auditor
Roselabs Bioscience Limited is audited by RAMANI & VASOYA for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMANI & VASOYA | FY 2020 | 135828W |
Shareholding
The shareholding of Roselabs Bioscience Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Roselabs Bioscience Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jun 2013 | 10436898 | State Bank of India | ₹71.38 Cr | Open | |
| 01 Sep 2012 | 10397072 | Axis Bank Limited | ₹17.59 Lakh | Open | |
| 11 Jun 2012 | 10359965 | State Bank of India | ₹29.74 Cr | Open | |
| 26 Oct 2010 | 10249587 | State Bank of India | ₹165.67 Cr | Open | |
| 26 Oct 2010 | 10249588 | State Bank of India | ₹195.41 Cr | Open |
To see the full charge records of Roselabs Bioscience Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Roselabs Bioscience Limited has 13 deals on record (7 funding rounds, 6 secondary share transfers), with disclosed funding of ₹94.34 Cr; the latest was in March 2019.
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Roselabs Helathcare Private Limited, Kriptol Industries Limited , Pushpdant Comotrade Private Limited, an individual Seller: Gopalka Motor Investo Pvt. Ltd. , 3 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: Pushpdant Comotrade Private Limited, Gopalka Motor Investo Pvt. Ltd. , an individual Seller: Kriptol Industries Limited , an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Kriptol Industries Limited Seller: Pushpdant Comotrade Private Limited, an individual |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: Pushpdant Comotrade Private Limited, Gopalka Motor Investo Pvt. Ltd. , an individual Seller: Kriptol Industries Limited |
| Jan 2013 | Funding round | ₹21.41 Cr | Investors: Pushpdant Comotrade Private Limited, Gopalka Motor Investo Pvt. Ltd. , Kriptol Industries Limited |
To see the full deal history of Roselabs Bioscience Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Roselabs Bioscience Limited has 67 court cases on record: 4 filed by Roselabs Bioscience, 63 filed against it. 30 cases are pending and 37 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 49 | 49 | 28 |
| NCLT | 8 | 5 | 0 |
| NCLAT | 5 | 5 | 0 |
| High courts | 4 | 3 | 2 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 67)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Ms Somnath Merchandise Pvt. Ltd. | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Ms Wrinkle Marketing Pvt. Ltd. | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by 1. Wrinkle Marketing Private Limited and 1 other | Disposed |
| Supreme Court | Appeal | Filed against the company by Wrinkle Marketing Private Limited | Disposed |
| NCLAT, Interlocutory Application | Interim or miscellaneous application | Filed against the company by 1. Wrinkle Marketing Private Limited and 1 other | Disposed |
To see the full case history of Roselabs Bioscience Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Roselabs Bioscience Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Roselabs Bioscience Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
Roselabs Bioscience has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Roselabs Bioscience Limited, buy the company report.
Recent activity
Roselabs Bioscience Limited has 7 board changes on record since 2010: 3 appointments and 4 cessations. The latest: Gaurang Atmaram Patel ceased to be Director on 21 May 2016.
10 earlier events are in the company report.
Frequently asked questions
Roselabs Bioscience is an active public limited company based in Ahmedabad, Gujarat, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 06 January 2010 (16+ years old) and is registered under CIN U24290GJ2010PLC059109.
Roselabs Bioscience has 3 current directors:
- Pawankumar Trilokchand Agrawal - Director
- Rahul Rajkumar Agrawal - Director
- Zameer Pawankumar Agrawal - Director
The latest financial statements of Roselabs Bioscience on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
No. Roselabs Bioscience has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Roselabs Bioscience is U24290GJ2010PLC059109. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Roselabs Bioscience has 67 court cases on record: 4 filed by the company and 63 filed against it. 30 are pending. Most are in the district courts.
Roselabs Bioscience was incorporated on 06 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Roselabs Bioscience has 13 deals on record (7 funding rounds, 6 secondary share transfers), with disclosed funding of ₹94.34 Cr; the latest was in March 2019.
The peers of Roselabs Bioscience by revenue are Outcare Medical Devices Private Limited, Peekay Mediequip Limited, Sangam Health Care Products Ltd, H&H Health Care & Cosmetics Private Limited, all in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gaurang Atmaram Patel ceased to be Director on 21 May 2016. Rahul Rajkumar Agrawal was appointed as Director on 21 May 2016. Gupta Mohit ceased to be Director on 09 Oct 2013. Roselabs Bioscience has 7 board changes on record in total.
Roselabs Bioscience can be reached through the website roselabsindia.com. Its registered office is in Ahmedabad, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
